Buscar
01/12/2025
Sources of essential lipids for Mycoplasma pneumoniae via P116 to target liver and atherosclerotic lesions
Vizarraga, D, Marcos, M, Rotllan, N, Martín, J, Santos, D, Camacho, M, Soto, B, Velasco-Reniu, L, Guerra, P, Pareja, F, Collantes, M, Wu, WL, Rodríguez-Arce, I, Serrano, L, Piñol, J, Fita, I, Escolà-Gil, JC. Sources of essential lipids for Mycoplasma pneumoniae via P116 to target liver and atherosclerotic lesions. Nature Communications. 2025; 16(1)DOI:10.1038/s41467-025-66129-5. PMID:41402265. IF:15.700(Q1/1D).
01/12/2025
Baseline Plasma Protein Signatures and Differential Molecular Responses to Dupilumab in Atopic Dermatitis Patients
Serra, E, Cantó, E, Gely, C, Pont, M, Trincado, J, Crespo, M, Vidal, S, Puig, L. Baseline Plasma Protein Signatures and Differential Molecular Responses to Dupilumab in Atopic Dermatitis Patients. JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2025; 145(12)DOI:. PMID:. IF:5.700(Q1/1D).
01/12/2025
Clinical and Economic Impact of Hybrid Closed-Loop Systems for T1 Diabetes Management in Spain
Khan-Miron, A, Syleouni, ME, Brusaferri, G, Nyffeler, M, Chico, A, Moreno-Fernandez, J, Beato-Víbora, PI. Clinical and Economic Impact of Hybrid Closed-Loop Systems for T1 Diabetes Management in Spain. Endocrine Practice. 2025; 31(12)DOI:10.1016/j.eprac.2025.08.002. PMID:40774615. IF:4.600(Q1/3D).
01/12/2025
Incidence and Survival of Colorectal Cancer in the United Kingdom From 2000 to 2021: A Population-Based Cohort Study
Pedregal-Pascual, P, Guarner-Argente, C, Tan, EH, Golozar, A, Duarte-Salles, T, Rosen, AW, Delmestri, A, Man, WY, Burn, E, Prieto-Alhambra, D, Newby, D. Incidence and Survival of Colorectal Cancer in the United Kingdom From 2000 to 2021: A Population-Based Cohort Study. AMERICAN JOURNAL OF GASTROENTEROLOGY. 2025; 120(12)DOI:10.14309/ajg.0000000000003460. PMID:40167184. IF:7.600(Q1/1D).
01/12/2025
Stability of Asthma Biomarkers Over a Two-year Period Using Three Distinct Classifications in the MEGA Cohort
Betancor, D, Rial, MJ, Olaguibel, JM, Del Pozo, V, Puebla, MJA, Arismendi, E, Barroso, B, Bobolea, I, Cárdaba, B, Cañas, JA, Domínguez-Ortega, J, Crespo-Leshman, A, Cruz, MJ, de la Fuente, AG, González-Barcalai, FJ, Luna-Portac, JA, Martínez-Rivera, C, Mullol, J, Muñoz, X, Plaza, V, Quirce, S, Soto-Retes, L, Valverde-Monge, M, Sastre, J. Stability of Asthma Biomarkers Over a Two-year Period Using Three Distinct Classifications in the MEGA Cohort. ARCHIVOS DE BRONCONEUMOLOGIA. 2025; 61(12)DOI:10.1016/j.arbres.2025.06.016. PMID:40707281. IF:9.200(Q1/1D).
01/12/2025
Early Failure, Late Failure, and Sustained Response to Biologics in Severe Asthma: A Long-term, Real-world, Multicentre study
Rivas, DD, Martinez-Moragon, E, Plaza, V, Serrano, CC, Benchimol, C, Flores, HI, Sánchez-Cuéllar, S, Martinez-Pitarch, MD, Aracil, CF, Alonso, AT, Rebollo, JCS, Gambasica, ZV, Campos, RMD, Mulato, PT, Gimeno, IE, Laorden, D, Arismendi, E, Malanda, NM, Damia, AD, Galvan, MF, Dávila, I, Bobo, JOD, Cosio, BG, de Llano, LAP. Early Failure, Late Failure, and Sustained Response to Biologics in Severe Asthma: A Long-term, Real-world, Multicentre study. ARCHIVOS DE BRONCONEUMOLOGIA. 2025; 61(12)DOI:10.1016/j.arbres.2025.04.003. PMID:40348717. IF:9.200(Q1/1D).
01/12/2025
Biomarkers in Sarcoidosis: From Traditional Markers to Precision Medicine
Pascual, MB, Zapata-Huizi, JJ, Ramos, D, Francesqui, J, Alsina-Restoy, X, Hernández-González, F, Sellares, J. Biomarkers in Sarcoidosis: From Traditional Markers to Precision Medicine. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE. 2025; 46(06)DOI:10.1055/a-2741-2030. PMID:41213628. IF:2.700(Q2/5D).
01/12/2025
Perioperative pembrolizumab in early-stage non-small-cell lung cancer (NSCLC): 5-year follow-up from the KEYNOTE-671 global study and Asian subgroup
Tsuboi, M, Wakelee, H, Spicer, JD, Gao, S, Liberman, M, Kato, T, Chen, KN, Dooms, C, Majem, M, Martinengo, GL, Bylicki, O, Abreu, DR, Halmos, B, Jones, DR, Chaft, J, Reck, M, Jense, E, Keller, SM, Samkari, A, Garassino, MC. Perioperative pembrolizumab in early-stage non-small-cell lung cancer (NSCLC): 5-year follow-up from the KEYNOTE-671 global study and Asian subgroup. ANNALS OF ONCOLOGY. 2025; 36DOI:10.1016/j.annonc.2025.10.607. PMID:. IF:65.400(Q1/1D).